None
Quote | Valneva Se Ord (OTCMKTS:INRLF)
Last: | $3.82 |
---|---|
Change Percent: | 100.0% |
Open: | $0 |
Close: | $3.82 |
High: | $0 |
Low: | $0 |
Volume: | 4 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
News | Valneva Se Ord (OTCMKTS:INRLF)
Saint-Herblain (France), March 26, 2024 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced the initiation of a Phase 1 clinical trial to investigate the the safety and immunogenicity of VLA1601, its second-generation adjuvanted inac...
Saint-Herblain (France), March 25, 2024 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, announced today the filing, on March 22, 2024, of its 2023 Universal Registration Document (URD) with the French Financial Markets Authority (AMF) under the filing n...
Message Board Posts | Valneva Se Ord (OTCMKTS:INRLF)
Subject | By | Source | When |
---|---|---|---|
chartguy89: INRLF 7.50 Stock Charts $INRLF 1 Month Chart | chartguy89 | investorshangout | 03/08/2014 4:19:03 AM |
chartguy89: INRLF Stock Charts Last: +2.02 Thursday, February 27, 2014 at 3:19:01 AM $INRLF | chartguy89 | investorshangout | 02/27/2014 8:19:12 AM |
News, Short Squeeze, Breakout and More Instantly...
Valneva Se Ord Company Name:
INRLF Stock Symbol:
OTCMKTS Market:
Saint-Herblain (France), March 26, 2024 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced the initiation of a Phase 1 clinical trial to investigate the the safety and immunogenicity of VLA1601, its second-generation adjuvanted inac...
Saint-Herblain (France), March 25, 2024 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, announced today the filing, on March 22, 2024, of its 2023 Universal Registration Document (URD) with the French Financial Markets Authority (AMF) under the filing n...
Saint-Herblain (France), March 21, 2024 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced it will present on its single-shot chikungunya vaccine, IXCHIQ ® , moderate a roundtable on the Zika and chikungunya viruses, and partic...